Pulmonary Tuberculosis
📧 Sign up to get email alerts when something new happens for Pulmonary Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Study About Drug Resistance of Mycobacterium Tuberculosis
A Sohag University–sponsored clinical trial is studying drug resistance in Mycobacterium tuberculosis affecting pulmonary and extrapulmonary…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis [Phase 2]
Phase 2 trial evaluating a short-course regimen with bedaquiline, moxifloxacin, and pyrazinamide for early bactericidal activity in drug-sus…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease [Phase 3]
This document reports an update on a Phase 3 clinical trial evaluating a shorter rifampicin-based treatment for people with less severe tube…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Ultra-Short Regimen for Elderly DS-TB [Phase 3]
A Phase 3 clinical trial evaluating an ultra-short regimen for elderly patients with drug-susceptible pulmonary tuberculosis is not yet recr…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota [NA]
This clinical trial update describes a study evaluating Nyaditum Resae as a co-adjuvant during active pulmonary tuberculosis treatment and i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
A Zhejiang University-sponsored retrospective study examines perioperative risk factors that influence prognosis after lung transplantation.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline [Phase 2]
A Phase 2 trial led by Makerere University is investigating doxycycline to characterize and prevent tuberculosis-associated lung fibrosis an…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Novel Triple-dose Tuberculosis Retreatment Regimen [Phase 3]
A Phase 3 clinical trial evaluating a novel triple-dose retreatment regimen for multidrug-resistant and pulmonary tuberculosis is currently …
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Pulmonary Aspergillosis in Tuberculosis Patients
A clinical trial update shows an active-not-recruiting study on pulmonary aspergillosis in patients with tuberculosis, examining overlap bet…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort [Phase 3]
Phase 3 trial update describing an all-oral, shorter, individualized regimen for rifampicin-resistant tuberculosis using contezolid, delaman…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda [NA]
Completed Ugandan clinical trial assessing a human-centered design and communities of practice approach to improve home-based tuberculosis c…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
A recruiting clinical trial aims to identify multiple pulmonary diseases by using volatile organic compound biomarkers in exhaled breath.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial [Phase 3]
Multicenter Phase 3 randomized, active-controlled trial evaluating a short-course regimen for low-risk active pulmonary tuberculosis. Recrui…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis [Phase 2]
Phase 2 trial evaluating TBAJ876 or bedaquiline, with pretomanid and linezolid, for adults with drug-sensitive pulmonary tuberculosis.
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India [NA]
A clinical trial in India is evaluating urine isoniazid testing as a method to detect nonadherence to tuberculosis medications. The study st…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Post TB Sequelae Study
Clinical trial update on a study evaluating post-tuberculosis sequelae; the trial is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis [NA]
The study, sponsored by Universidade Federal do Rio de Janeiro, is evaluating cardiopulmonary function and quality of life in individuals wi…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: A Systemic Screening for TB Disease in High-risk Groups in Barcelona
A clinical trial in Barcelona is testing systemic screening for tuberculosis disease in high-risk groups. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis [EARLY_Phase 1]
An early-phase observational study assessing Yiqi Gubiao Pill for chronic obstructive pulmonary disease secondary to active pulmonary tuberc…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB) [Phase 4]
Phase 4 clinical trial assessing the safety and efficacy of a bedaquiline-delamanid-linezolid regimen in pulmonary MDR-TB and rifampicin-res…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis [Phase 4]
Phase 4 clinical trial evaluating BaiDiZiYin ShenQiYiFei as an adjunctive treatment for pulmonary tuberculosis; currently recruiting.
-
CLINICAL_TRIALS research · 2024-04-22Clinical Trial Update: Economic Evaluation of New MDR TB Regimens [Phase 2, Phase 3]
A clinical trial update evaluating the economic aspects of new regimens for multidrug-resistant and extensively drug-resistant tuberculosis …
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection [Phase 2]
A Phase 2 clinical trial compares the RIPE tuberculosis regimen alone versus RIPE with added N-acetylcysteine in patients co-infected with H…
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis [NA]
A clinical trial compares rifampicin versus rifabutin in patients with HIV/AIDS and pulmonary tuberculosis.
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection
Clinical trial update examining IGRA (interferon-gamma release assay) and Mantoux test responses in children with suspected latent or active…